FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom

FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom

Source: 
Xconomy
snippet: 

The treatment landscape for hemophilia is changing fast, and today marks a turning point. The FDA has just cleared Roche to sell its drug emicizumab (Hemlibra) to patients with any form of hemophilia A—making it, potentially, the choice treatment for the disease. At least for now.